Amati AIM VCT plc (MRV) Fair Value & Analysis
Financial Services · GB · Market cap 67.1M GBX
Fair value as of: Jul 15, 2026
From 1 valuation models · updated today
Fair value updated Jul 15, 2026 — revised from £1.06 to £0.4500 (−57.5%) since Jun 26, 2026. Share price −1.4% over the past month.
Price vs Fair Value (12 months)
12‑month range £0.4956 – £0.5604 · fair‑value band £0.3400 – £0.6700 · the £0.5250 price screens above the £0.4500 fair value. As of Jul 15, 2026.
✦ Which stocks are undervalued right now? Check free Discover now →Analysis
Amati AIM VCT plc (MRV) currently trades at £0.5250, while our model-based Fair Value estimate is £0.4500 — implying the stock looks roughly 14.3% overvalued today. We read business quality at 66/100 (solid quality), in the Financial Services sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: low).
Revenue declined 40.6% year over year. It earns a return on equity of -5.8%. Fundamentals as of Jul 15, 2026
Our scenario range runs from £0.3400 (bear case) to £0.6700 (bull case); at £0.5250, the current price sits within that range. For context, the median of 10 Financial Services peers we cover trades at 53% fair-value upside — at -14%, MRV screens richer than that median.
Key figures & financial health
More key figures
Figures from reported company fundamentals (EODHD) · as of Jul 15, 2026. TTM = trailing twelve months.
About the company
Amati AIM VCT plc (LSE:AMAT) is a venture capital trust specializing in growth capital investment. It investments in AIM quoted companies. The fund seeks to invest in technology, industrials, financials, consumer services, financials, healthcare, consumer goods and services, oil and gas, basic materials, telecommunications, and utilities. The fund invests in companies based in the United Kingdom. It also invests in unquoted companies, plus markets, and listed securities.
Revenue & earnings trend
FY2022 – FY2026 · reported fiscal years
Amati AIM VCT plc reported revenue of £897K in FY2026 versus −£21.9M in FY2022. Reported net income was −£881K in FY2026.
Is MRV fairly valued? → Check now
Similar stocks
10 more Asset Management stocks, each showing price versus our Fair Value estimate (as of Jul 15, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Fondul Proprietatea SA FP | $4.20 | $6.41 | +53% |
| The Schiehallion Fund Limited MNTN | $0.0214 | $0.0400 | +87% |
| BlackRock, Inc BLK | $1,019 | $597.61 | -41% |
| Blackstone Inc BX | $118.55 | $61.04 | -49% |
| BH Macro Limited BHMU | $4.42 | $8.84 | +100% |
| Investor AB INVEB | kr 377.85 | kr 1,417 | +275% |
| BioPharma Credit PLC BPCR | $0.0095 | $0.0200 | +111% |
| Brookfield Corporation BN | $44.13 | $11.09 | -75% |
| KKR & Co KKR | C$21.40 | C$5.96 | -72% |
| Brookfield Asset Management Ltd BAM | $45.70 | $32.37 | -29% |
Explore undervalued stocks
More undervalued Financial Services stocks →
Frequently asked questions
Is Amati AIM VCT plc (MRV) undervalued?
What is the fair value of MRV?
What is the quality score of MRV?
What is the net profit margin of MRV?
Does Amati AIM VCT plc pay a dividend?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Tell me when Amati AIM VCT plc reaches its Fair Value
Just your email — and we'll notify you when the price and Fair Value of Amati AIM VCT plc materially change. Free bonus: the monthly Top-25 report of the most undervalued quality stocks.
Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click. Not financial advice.
Not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.